Across 107 enterprises, AI agents are being given real access to systems and data while the controls meant to contain them ...

Your company likely uses hundreds of SaaS apps, but your security team is probably blind to who actually has access to them.

Across 107 enterprises, AI infrastructure spending is accelerating well ahead of the ability to see or steer its economics.

Merck's LIPFENDRA (enlicitide), the first FDA-approved oral PCSK9 inhibitor, approved 16 July 2026 at a list price of $315 for a 30-day supply. Amgen's Repatha (evolocumab) is already available for ...